Immunoregulatory networks in asthma

Area of Science:

• Immunology
• Allergy and Asthma Research

Background:

• T-helper 2 (Th2) cytokines are key drivers of atopic airway diseases, influencing inflammation, mucus production, and immune cell infiltration.
• Previous attempts to inhibit Th2 cytokine-producing cells have faced challenges.
• Recent advances in understanding T-cell activation and maturation molecules offer new therapeutic avenues.

Purpose of the Study:

• To explore novel therapeutic strategies for atopic airway inflammation by targeting T-cell activation pathways.
• To identify potential agents for blocking Th2 cell activity in allergic airway diseases.

Main Methods:

• Investigating antagonists of T-cell costimulatory molecule CD28.
• Exploring local stimulators of T-helper 1 (Th1) cytokines, such as BCG vaccine.
• Examining antagonists of the eotaxin chemokine receptor.
• Considering agonists of the T-cell costimulatory molecule CTLA-4.

Main Results:

• Identification of several promising agents for modulating Th2 cell activity.
• Demonstration of successful blocking of Th2 cell activities in models of atopic airway inflammation.
• Potential therapeutic agents include CD28 antagonists, Th1 stimulators, eotaxin receptor antagonists, and CTLA-4 agonists.

Conclusions:

• Targeting T-cell costimulatory molecules and chemokine receptors offers a promising approach for treating atopic airway diseases.
• These agents not only represent potential therapies but also valuable tools for understanding disease mechanisms.
• Further research into these modulators could lead to improved diagnostics and treatments for allergic airway conditions.